menu
    • menu

    Company profile for Xentria

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Focused on becoming a critical leader in the biopharma industry through a strong portfolio of products having purpose for patients. Driven to treat the clinical and social burdens of diseases while fostering sustainable growth.Focused on becoming a critical leader in the biopharma industry through a strong portfolio of products having purpose for patients. Driven to treat the clinical and social burdens of diseases while foste...
    Focused on becoming a critical leader in the biopharma industry through a strong portfolio of products having purpose for patients. Driven to treat the clinical and social burdens of diseases while fostering sustainable growth.Focused on becoming a critical leader in the biopharma industry through a strong portfolio of products having purpose for patients. Driven to treat the clinical and social burdens of diseases while fostering sustainable growth.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    XentriaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    8700 W Bryn Mawr Ave Ste 600S Chicago, IL
    Telephone
    Telephone
    +1 224-443-4615
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.xentria.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/xentria-inc/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Xentria Launches Xturnpoint And Expands Headquarters
    Xentria Launches Xturnpoint And Expands Headquarters

    22 May 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/xentria-launches-xturnpoint-to-fuel-early-stage-therapeutic-innovation-expands-headquarters-to-support-growth-302460623.html

    PR NEWSWIRE
    22 May 2025
    Share Share
    Xentria Advances XTMAB16 Study in Pulmonary Sarcoidosis
    Xentria Advances XTMAB16 Study in Pulmonary Sarcoidosis

    18 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/xentria-advances-xtmab16-study-in-pulmonary-sarcoidosis-with-completed-enrollment-and-key-conference-selections-302403516.html

    PR NEWSWIRE
    18 Mar 2025
    Share Share
    Xentria Achieves Milestone Success with Biosimilar Development
    Xentria Achieves Milestone Success with Biosimilar Development

    08 Jan 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/expanding-horizons-xentria-achieves-milestone-success-with-biosimilar-development-302346481.html

    PR NEWSWIRE
    08 Jan 2025
    Share Share
    Xentria’s XTMAB-16 Receives Orphan Drug Designation From EMA
    Xentria’s XTMAB-16 Receives Orphan Drug Designation From EMA

    15 Nov 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231115747602/en

    BUSINESSWIRE
    15 Nov 2023
    Share Share
    Meitheal pays Xentria $45M for right to TNF drug in lung disease
    Meitheal pays Xentria $45M for right to TNF drug in lung disease

    27 Jun 2023

    // Nick Paul Taylor FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/meitheal-bets-there-still-life-tnf-inhibitors-paying-xentria-45m-rights-lung-disease

    Nick Paul Taylor FIERCE BIOTECH
    27 Jun 2023
    Share Share
    Xentria Announces Peer Reviewed Publication of Biosimulation Model
    Xentria Announces Peer Reviewed Publication of Biosimulation Model

    21 Mar 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230321005189/en

    BUSINESSWIRE
    21 Mar 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search